Phenomenal Time To Buy GOLD STOCKS! | Adrian Day

In this interview, Adrian Day, President of Adrian Day Asset Management, discusses the disconnect between gold stocks and record gold prices.

Day explains why major gold ETFs have seen no inflows despite high prices. He predicts a catalyst that could push gold above $3,000 and offers an unexpected perspective on fundraising ease in Canadian junior mining.

He also shares insights on precious metals investments in current market conditions.


Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security. The Deep Dive and its affiliates hold no licenses.

Video Articles

Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic

Agnico Eagle Just Made a Massive Gold Land Grab

A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold

Recommended

Antimony Resources Expands Footprint as Soil Sampling Lights Up Ground South of Bald Hill

Mercado Drills 256 g/t Silver Over 6.5 Metres In First Drill Hole of Inaugural Program

Related News

BMO Reiterates $72 Price Target On Kirkland Lake Gold

Last week, Kirkland Lake Gold Ltd. (TSX: KL) announced their second quarter production figures. Results...

Wednesday, July 21, 2021, 11:20:00 AM

Bubba Horwitz: This Is Not Transitory Inflation – The Daily Dive

Today on the Daily Dive, we welcome back Todd Bubba Horwitz, CEO of Bubba Trading....

Wednesday, August 18, 2021, 01:30:00 PM

Yamana Gold Becomes Strategic Investor In Freeman Gold

Yamana Gold (TSX: YRI) has become a strategic shareholder in Freeman Gold (CSE: FMAN), with...

Tuesday, September 8, 2020, 09:23:18 AM

JPMorgan CEO Says Gold Could Hit $10,000 in Current Environment

JPMorgan Chase CEO Jamie Dimon said Tuesday that gold prices could surge to $5,000 or...

Thursday, October 16, 2025, 12:53:00 PM

McDonald’s E.coli Crisis: This Canadian Biotech May Have The Solution | Cytophage with Steven Theriault

In this interview, Dr. Steven Theriault, CEO & Chief Science Officer of Cytophage Technologies (TSXV:...
Saturday, November 16, 2024, 09:13:00 AM